Ovarian cancer kills an estimated 12,700 women annually, with around 20,000 women getting a diagnosis each year.

In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who received interval debulking surgery compared to primary debulking surgery.

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...

Please provide your email address to receive an email when new articles are posted on . Fertility-sparing surgery resulted in similar overall 5-year survival rates as non-sparing surgery.

CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.

In a medical first, four women have undergone a two-in-one operation to deliver a baby as well as cut their risk of ovarian cancer. A caesarean surgery and ovary removal are usually two standalone ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

CHICAGO - Known as 'the silent killer' due to its lack of symptoms and reliable screening tests, ovarian cancer remains one ...